Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published May 22, 2020

Acella NP Thyroid 60 Tablets Recall: Superpotent Drug Risk

Acella Pharmaceuticals recalls 100-count NP Thyroid 60 tablets (60 mg) due to superpotent drug risk. Rx-only medication with specific lot numbers and expiration date.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1299-2020DrugAcella ›
Take action

Contact the company

Recalling firmAcella Pharmaceuticals, LLC1880 Mcfarland Pkwy Ste 110-B · Alpharetta, GA 30005
✎ GovInfoNow plain-language explainer

Acella Pharmaceuticals is recalling 100-count NP Thyroid 60 tablets (60 mg) because they contain a superpotent drug that could cause serious harm if taken incorrectly. This recall applies to prescription-only medication with specific lot numbers and an expiration date of August 2020. Read more at govinfonow.com/recall/37104-acella-np-thyroid-60-tablets-recall-superpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37104-acella-np-thyroid-60-tablets-recall-superpotent-drug-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1299-2020

Cite this page

“Acella NP Thyroid 60 Tablets Recall: Superpotent Drug Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37104-acella-np-thyroid-60-tablets-recall-superpotent-drug-risk. Based on FDA recall #D-1299-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1299-2020%22&limit=1).

The FDA announced on May 22, 2020, that Acella Pharmaceuticals voluntarily recalled NP Thyroid 60 tablets due to superpotent drug risks. The agency issued recall number D-1299-2020 for the affected lots.

How to tell if you have it

  • Brand: Acella
  • Product: NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles
  • NDC: 42192-330-01
  • Lots: M330J18-2A, M330J18-3
  • Expiration: AUG-2020
  • Quantity: 29,304 bottles

The hazard

The recall addresses the hazard of a superpotent drug. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show Acella Pharmaceuticals, LLC has had 7 other recalls since September 17, 2020. Recent brand recalls include an April 24, 2024 sodium sulfacetamide cleanser recall for subpotent drug issues and a September 29, 2025 doxycycline tablet recall for failed dissolution testing. Other recent recalls of similar products include Vitruvias Thyroid Tablets Recall (August 21, 2026), Accord Healthcare Levothyroxine Tablets Recall (August 6, 2026), and Major Pharmaceuticals Levothyroxine Tablets Recall (July 13, 2026).

How to tell if you have this one

Check for NP Thyroid 60 tablets (60 mg) with lot numbers M330J18-2A or M330J18-3. The product was manufactured for Acella Pharmaceuticals in Alpharetta, GA and expires August 2020.

  • Brand
    Acella
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Terminated
  • Distribution
    Distributed Nationwide in the US and Puerto Rico
  • NDC
    42192-327-01, 42192-327-30, 42192-327-90, 42192-329-01, 42192-329-30, 42192-329-10, 42192-329-90, 42192-330-01, 42192-330-30, 42192-330-10, 42192-330-90, 42192-331-01, 42192-331-30, 42192-331-10, 42192-331-90, 42192-328-01, 42192-328-30, 42192-328-90
Recall numberProduct, codes & lotsQuantity
D-1298-2020NP Thyroid 30, Thyroid Tablets, USP, 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-329-01.; Lots: M329H18-1, Exp. JUL-2020; M329J18-1, M329J18-2, M329J18-3 Exp. AUG-2020; M329M18-2 Exp. NOV-2020, M329A19-1 Exp. DEC-2020.112,140 bottles
D-1299-2020NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-330-01.; Lots: M330J18-2A, M330J18-3 Exp. AUG-202029,304 bottles
D-1300-2020NP Thyroid 90, Thyroid Tablets, USP, 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-331-01.; Lots: M331G18-1 Exp. JUN-2020, M331J18-1, M331J18-2, Exp. AUG-2020, M331M18-1, M331M18-2 Exp. NOV-202049,128 bottles
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled NP Thyroid 60 tablets if you have them.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Distributed Nationwide in the US and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: May 22, 202012. FDA classified it Class I: Jun 8, 202023. Published in FDA’s Enforcement Report: Jun 10, 202034. FDA terminated the recall: Jan 19, 2022420202022
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Vitruvias Thyroid Tablets Recall: Superpotent Drug Risk
Vitruvias TherapeuticsQualitest Hydrocodone/Acetaminophen Recall: Superpotent Tablets
Qualitest PharmaceuticalsAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.

Other Acella recalls

Acella Pharmaceuticals, LLC recalls NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals,
April 20, 2026

Latest drug recalls

SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1299-2020 (May 22, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1299-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA